Translating...
Content is automatically generated by Microsoft Azure Translator Text API. CGTN is not responsible for any of the translations.
Share
Copied
U.S. regulators have authorized a second booster dose of Pfizer Inc and BioNTech SE's COVID-19 vaccine for people 50 and older due to concerns about waning immunity in the age group, the drugmakers said on Tuesday.
